Home > Annual Financials > STRIDES PHARMA SCIENCE

STRIDES PHARMA SCIENCE Financial Statement Analysis
[BOM: 532531|NSE : STAR]

The Revenues of STRIDES PHARMA SCIENCE have increased by 17.36% YoY .
The Earnings Per Share (EPS) of STRIDES PHARMA SCIENCE has increased by Positive YoY.
REVENUES
OPERATING MARGIN
PROFIT AFTER TAX
EPS
ROCE

STRIDES PHARMA SCIENCE Last 5 Annual Financial Results
[BOM: 532531|NSE : STAR]

ConsolidatedMar2025
Mar2024
Mar2023
Mar2022
Mar2021
Revenues ₹4,565 Cr₹3,890 Cr₹3,688 Cr₹3,070 Cr₹3,316 Cr
Expenses ₹3,768 Cr₹3,318 Cr₹3,303 Cr₹3,092 Cr₹2,689 Cr
Operating Profit (Excl OI) ₹798 Cr₹572 Cr₹385 Cr₹-22 Cr₹627 Cr
Other Income ₹64 Cr₹50 Cr₹135 Cr₹133 Cr₹59 Cr
Interest ₹249 Cr₹280 Cr₹261 Cr₹177 Cr₹150 Cr
Depreciation ₹192 Cr₹214 Cr₹243 Cr₹233 Cr₹206 Cr
Profit Before Tax ₹487 Cr₹-115 Cr₹-286 Cr₹-653 Cr₹275 Cr
Profit After Tax ₹409 Cr₹-144 Cr₹-231 Cr₹-474 Cr₹244 Cr
Consolidated Net Profit ₹3,593 Cr₹-71 Cr₹-203 Cr₹-460 Cr₹268 Cr
Earnings Per Share (Rs)₹389.90₹-7.68₹-22.44₹-51.25₹29.93
PAT Margin (%)5.77-2.36-3.70-8.904.45
ROE(%)17.52-6.67-10.15-18.499.21
ROCE(%)16.563.47-0.49-9.499.08
Total Debt/Equity(x)0.701.141.271.180.76

Key Financials

Market Cap : ₹ 8,094.2 Cr
Revenue (TTM) : ₹ 4,632.7 Cr
Net Profit(TTM) : ₹ 358.2 Cr
EPS (TTM) : ₹ 38.8
P/E (TTM) : 22.6

Industry Peers & Returns1W1M1Y
STRIDES PHARMA SCIENCE -4.3% 5.7% -6.5%
SUN PHARMACEUTICAL INDUSTRIES -1.3% 1% 7.9%
DIVIS LABORATORIES -3.2% -0.3% 48%
CIPLA -0.6% -2.2% -0.7%
TORRENT PHARMACEUTICALS 1.2% 10.7% 19.5%
DR REDDYS LABORATORIES -1.5% -5.9% -5.1%
MANKIND PHARMA 1.8% 16.1% 24.3%
ZYDUS LIFESCIENCES -1.3% 0.4% -15.3%
LUPIN -1.4% -1.3% 7.6%


STRIDES PHARMA SCIENCE Revenues
[BOM: 532531|NSE : STAR]

Y-o-Y

17.36 %

5 Yr CAGR

8.32 %

Years Revenues % Change
Mar2025 ₹4,565 Cr
17.36
Mar2024 ₹3,890 Cr
5.47
Mar2023 ₹3,688 Cr
20.13
Mar2022 ₹3,070 Cr
-7.41
Mar2021 ₹3,316 Cr -


STRIDES PHARMA SCIENCE Operating Profit
[BOM: 532531|NSE : STAR]

Y-o-Y

39.41 %

5 Yr CAGR

6.21 %

Years Operating Profit % Change
Mar2025 ₹798 Cr
39.41
Mar2024 ₹572 Cr
48.52
Mar2023 ₹385 Cr
Positive
Mar2022 ₹-22 Cr
Negative
Mar2021 ₹627 Cr -

Operating Margins
Y-o-Y

18.76 %

5 Yr CAGR

-1.95 %

Years Operating Margin% % Change
Mar2025 17.47%
18.76
Mar2024 14.71%
40.77
Mar2023 10.45%
Positive
Mar2022 -0.7%
Negative
Mar2021 18.9% -

STRIDES PHARMA SCIENCE Profit After Tax
[BOM: 532531|NSE : STAR]

Y-o-Y

Positive

5 Yr CAGR

91.28 %

Years Profit After Tax % Change
Mar2025 ₹3,593 Cr
Positive
Mar2024 ₹-71 Cr
Negative
Mar2023 ₹-203 Cr
Negative
Mar2022 ₹-460 Cr
Negative
Mar2021 ₹268 Cr -

PAT Margins
Y-o-Y

Positive

5 Yr CAGR

6.71 %

Years PAT Margin(%) % Change
Mar2025 5.77 %
Positive
Mar2024 -2.36 %
Negative
Mar2023 -3.7 %
Negative
Mar2022 -8.9 %
Negative
Mar2021 4.45 % -

STRIDES PHARMA SCIENCE Earnings Per Share (EPS)
[BOM: 532531|NSE : STAR]

Y-o-Y

Positive

5 Yr CAGR

89.98 %

Years EPS % Change
Mar2025 ₹390
Positive
Mar2024 ₹-7.68
Negative
Mar2023 ₹-22
Negative
Mar2022 ₹-51
Negative
Mar2021 ₹30 -

STRIDES PHARMA SCIENCE Return on Capital Employed (ROCE)
[BOM: 532531|NSE : STAR]

Y-o-Y

377.23 %

5 Yr CAGR

16.21 %

Years ROCE % Change
Mar2025 16.56%
377.23
Mar2024 3.47%
Positive
Mar2023 -0.49%
Negative
Mar2022 -9.49%
Negative
Mar2021 9.08% -

STRIDES PHARMA SCIENCE Share Price vs Sensex

Current Share Price : ₹877.9
Current MarketCap: ₹ 8,094.2 Cr
Updated EOD on :Jul 22,2025

Share Price Returns(%) 1 Week 1 Month 1 Year
STRIDES PHARMA SCIENCE

-4.3%

5.7%

-6.5%

SENSEX

-0.5%

-0.3%

1%

STRIDES PHARMA SCIENCE related INDICES

BSE Indices1W1M1Y
BSE ALLCAP 6.4% 8.9% 7.5%
BSE MIDSMALLCAP 4.7% 9% 8.4%
BSE SMALLCAP -0.2% 5.4% 2.8%
BSE HEALTHCARE -1.4% 3.8% 15.3%
NSE Indices1W1M1Y
NIFTY MICROCAP 250 NA 5.7% 3.3%
NIFTY TOTAL MARKET -0.5% 1.4% 0.6%
NIFTY MIDSMALL HEALTHCARE -1.2% 7.1% 19.9%

You may also like the below Video Courses


FAQ about STRIDES PHARMA SCIENCE Financials


How the annual revenues of STRIDES PHARMA SCIENCE have changed ?

The Revenues of STRIDES PHARMA SCIENCE have increased by 17.36% YoY .

How the Earnings per Share (EPS) of STRIDES PHARMA SCIENCE have changed?

The Earnings Per Share (EPS) of STRIDES PHARMA SCIENCE has increased by Positive YoY .